Table 2A.
Over expression of CD62L in bladder cancers
| Dataset | Fold change |
Gene Rank |
Number of samples (Invasive, Superficial) |
P-value | Meta-analysis |
|---|---|---|---|---|---|
| Upregulated expression in invasive bladder cancers | |||||
| Dyrskjot - 2003 | 7.88 | 110 | 40 (10, 30) | 1.88 E-4 | Median Rank = 127 P=4.21 E-6 |
| Modlich – 2004 | 3.62 | 462 | 9 (6, 3) | 7.00 E-3 | |
| Stransky – 2006 | 3.24 | 127 | 57 (32, 25) | 4.21 E-6 | |
| Upregulated expression in superficial bladder cancers | |||||
| Blaveri – 2005 | 1.80 | 411 | 65 (41, 24) | 1.11 E-4 | |
| Dyrskjot - 2004 | 1.60 | 857 | 27 (8, 19)* | 1.90 E-2 | |
*
(Grade 2, Grade 3)